Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
Go back to Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates| (NASDAQ: MNPR) | Delayed: 82.65 +13.99 (20.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.66 | 52 Week High | $ | |||
| Open | $68.21 | 52 Week Low | $ | |||
| Day High | $83.57 | P/E | N/A | |||
| Day Low | $68.21 | EPS | $ | |||
| Volume | 231,018 | |||||

